Traditional Antifungal Dermatologic Agents

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 22, Issue 5, 2000, Pages 461-468

  De Jaham, Caroline ^a,d,e   Paradis, Manon ^b,e   Papich, Mark G ^c,f  

^a Centre Vétérinaire DMV   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d DMV Veterinary Center   (Canada)

^e Amer Coll of Vet Dermatology   (United States)

^f Amer Coll of Vet Clin Pharmacol   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007173965     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Gupta AK, Sauder DN, Shear NH: Antifungal agents: An overview. Part I. J Am Acad Dermatol 30:677-698, 1994.
2. Rosychuk RAW: Management of otitis externa. Vet Clin North Am Small Anim Pract 24:921-952, 1994.
3. Armstrong D, Schmitt HJ: Older drugs, in Ryley JF (ed): Handbook of Experimental Pharmacology: Chemotherapy of Fungal Diseases. Berlin, Springer-Verlag, 1990, pp 439-453.
4. Greene CE: Antifungal chemotherapy, in Greene CE (ed): Infectious Diseases of Dogs and Cats. Philadelphia, WB Saunders Co, 649-658, 1989.
5. Atkinson AJ, Bennett JE: Amphotericin B pharmacokinetics in humans. J Antimicrob Chemother 13:271-276, 1978.
6. Van Der Horst CM, Saag MS, Cloud GA, et al: Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 337:15-21, 1997.
7. Hill P, Moriello KA, Shaw SE: A review of systemic antifungal agents. Vet Dermatol 6:59-66, 1995.
8. Legendre AM, Selcer BA, Edwards DF, Stevens R: Treatment of canine blastomycosis with amphotericin B and ketoconazole. JAVMA 184:1249-1254, 1984.
9. Noxon JO: Systemic antifungal chemotherapy, in Kirk RW (ed): Current Veterinary Therapy X. Philadelphia, WB Saunders Co, 1989, pp 1101-1105.
10. Rubin SI, Krawiec DR, Gelberg H, Shanks RD: Nephrotoxicity of amphotericin B in dogs: A comparison of two methods of administration. Can J Vet Res 53:23-28, 1989.
11. Guillot J, Chermette R, Maillard R: Les candidoses des carnivores domestiques: Actualisation à propos de 10 cas. Point Vét 28:51-60, 1996.
12. Stevens DA: Oral amphotericin B as an antifungal agent. J Mycol Med 6(Suppl II):1-2, 1996.
13. Malik R, Craig AJ, Wigney DI, Martin P, Love DN: Combination chemotherapy of canine and feline cryptococcosis using subcutaneously administered amphotericin B. Aust Vet J 73:124-128, 1996.
14. Legendre AM: Antimycotic drug therapy, in Bonagura JD, Kirk RW (eds): Current Veterinary Therapy. XII. Philadelphia, WB Saunders Co, 1995, pp 327-331.
15. Randall SR, Adams LG, White MR, DeNicola DB: Nephrotoxicity of amphotericin B administered to dogs in a fat emulsion versus five percent dextrose solution. Am J Vet Res 57:1054-1058, 1996.
16. Krawiec DR, McKiernan BC, Twardock RA, et al: Use of an amphotericin B lipid complex for treatment of blastomycosis in dogs. JAVMA 209:2073-2075, 1996.
17. Oliva G, Gradoni L, Ciaramella P, et al: Activity of liposomal amphotericin B (AmBisome) in dogs naturally infected with Leishmania infantum. J Antimicrob Chemother 36: 1013-1019, 1995.
18. Hiemenz JW, Walsh TJ: Lipid formulations of amphotericin B: Recent progress and future directions. Clin Infect Dis 22(Suppl 2):S133-S144, 1996.
19. Walsh TJ, Finberg RW, Arndt C, et al: Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. N Engl J Med 340:764-771, 1999.
20. Mikiciuk MG, Fales WH, Schmidt DA: Successful treatment of feline cryptococcosis with ketoconazole and flucytosine. JAAHA 26:199-201, 1990.
21. Aram H: Sporotrichosis: A historical approach. Int J Dermatol 25:203-205, 1986.
22. Werner AH, Werner BE: Feline sporotrichosis. Compend Contin Educ Pract Vet 15(9):1189-1198, 1993.
23. Moriello KA, Franks P, Delany-Lewis D, King R: Cutaneous-lymphatic and nasal sporotrichosis in a dog. JAAHA 24:621-626, 1988.
24. Rosser EJ, Dunstan RW: Sporotrichosis, in Greene CE (ed): Infectious Diseases of Dogs and Cats. Philadelphia, WB Saunders Co, 1989, pp 707-710.
25. Rosser EJ: Sporotrichosis, in Griffin CE, Kwochka KW, McDonald JM (eds): Current Veterinary Dermatology. St. Louis, Mosby Year Book, 1993, pp 49-53.
26. Foil CS: Subcutaneous mycoses. Proc Annu Members Meet Am Acad Vet Dermatol/Am Coll Vet Dermatol: 17-25, 1997.
27. Gentles GC: Experimental ringworm in guinea pigs: Oral treatment with griseofulvin. Nature 182:476-477, 1958.
28. William DI, Marten RH, Sarkany I: Oral treatment of ringworm with griseofulvin. Lancet 2:1212-1213, 1958.
29. McNall EG: Biochemical studies on the metabolism of griseofulvin. Arch Dermatol 81:657-661, 1960.
30. Sorrentino L, Capasso F, Di Rosa M: Antiinflammatory properties of griseofulvin. Agents Actions Suppl 7:157-162, 1977.
31. Harris PA, Riegelman S: Metabolism of griseofulvin in dogs. J Pharm Sci 58:93-96, 1969.
32. Epstein WL, Shah VP, Riegelman S: Griseofulvin levels in stratum corneum. Arch Dermatol 106:344-348, 1972.
33. Anderson DW: Griseofulvin: Biology and clinical usefulness. Ann Allergy 23:103-110, 1965.
34. DeBoer DJ, Moriello KM, Cairns R: Clinical update on feline dermatophytosis - Part II. Compend Contin Educ Pract Vet 17(12):1471-1480, 1995.
35. Moriello KA, DeBoer DJ: Feline dermatophytosis: Recent advances and recommendations for therapy. Vet Clin North Am Small Anim Pract 25:901-921, 1995.
36. Scott DW, Miller WH Jr, Griffin CE: Fungal skin diseases, in Scott DW, Miller WH Jr, Griffin CE, (eds): Small Animal Dermatology, ed 5. Philadelphia, WB Saunders Co, 1995, pp 329-391.
37. Puccini S, Valdré A, Rapini R, Mancianti F: In vitro susceptibility to antimycotics of Microsporum canis isolates from cats. JAVMA 201:1375-1377, 1992.
38. Helton KA, Nesbitt GH, Caciolo PL: Griseofulvin toxicities in cats: Literature review and report of seven cases. JAAHA 22: 453-458, 1986.
39. Scott DW: Fungal disorders: Feline dermatology 1900-1978: A monograph. JAAHA 16:349-356, 1980.
40. Shelton GH, Grant CK, Linenberg ML, Abkowitz JL: Severe neutropenia associated with griseofulvin therapy in cats with feline immunodeficiency virus infection. J Vet Intern Med 4:317-319, 1990.
41. Scott DW, De Lahunta AD, Schultz RD, et al: Teratogenesis in cats associated with griseofulvin therapy. Teratology 11:79-86, 1975.
42. Wyrobek AJ, Bruce WR: Chemical induction of sperm abnormalities in mice. Proc Natl Acad Sci USA 72:4425-4429, 1975.